A new trading day began on Monday, with Vanda Pharmaceuticals Inc (NASDAQ: VNDA) stock price down -4.61% from the previous day of trading, before settling in for the closing price of $8.25. VNDA’s price has ranged from $3.81 to $9.60 over the past 52 weeks.
Meanwhile, its annual earnings per share averaged -709.85%. With a float of $55.08 million, this company’s outstanding shares have now reached $59.10 million.
Vanda Pharmaceuticals Inc (VNDA) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Vanda Pharmaceuticals Inc is 6.79%, while institutional ownership is 77.31%. The most recent insider transaction that took place on Aug 07 ’25, was worth 41,500. In this transaction President and CEO of this company bought 10,000 shares at a rate of $4.15, taking the stock ownership to the 2,335,731 shares. Before that another transaction happened on Jun 13 ’25, when Company’s Director sold 7,000 for $4.59, making the entire transaction worth $32,130. This insider now owns 97,082 shares in total.
Vanda Pharmaceuticals Inc (VNDA) Latest Financial update
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -0.08 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.42 per share during the current fiscal year.
Vanda Pharmaceuticals Inc (NASDAQ: VNDA) Trading Performance Indicators
Here are Vanda Pharmaceuticals Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 3.10. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.19.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.43, a number that is poised to hit -0.97 in the next quarter and is forecasted to reach -1.45 in one year’s time.
Technical Analysis of Vanda Pharmaceuticals Inc (VNDA)
The latest stats from [Vanda Pharmaceuticals Inc, VNDA] show that its last 5-days average volume of 7.46 million was superior to 3.98 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 56.04%.
During the past 100 days, Vanda Pharmaceuticals Inc’s (VNDA) raw stochastic average was set at 67.54%, which indicates a significant increase from 46.77% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.49 in the past 14 days, which was higher than the 0.27 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.67, while its 200-day Moving Average is $4.87. Now, the first resistance to watch is $8.28. This is followed by the second major resistance level at $8.70. The third major resistance level sits at $8.91. If the price goes on to break the first support level at $7.65, it is likely to go to the next support level at $7.44. The third support level lies at $7.02 if the price breaches the second support level.
Vanda Pharmaceuticals Inc (NASDAQ: VNDA) Key Stats
With a market capitalization of 465.09 million, the company has a total of 59,097K Shares Outstanding. Currently, annual sales are 198,770 K while annual income is -18,900 K. The company’s previous quarter sales were 56,260 K while its latest quarter income was -22,590 K.
